# TGFB2

## Overview
The TGFB2 gene encodes the protein transforming growth factor beta 2 (TGF-β2), a member of the TGF-beta superfamily, which is known for its regulatory roles in cellular processes such as growth, differentiation, and apoptosis. TGF-β2 is a secreted signaling molecule that functions primarily as a cytokine, influencing a wide range of physiological and pathological processes. The protein is initially synthesized as a precursor that undergoes proteolytic cleavage to become active, featuring a cystine knot motif that is essential for its structural stability and function (Weiss2012The). TGF-β2 typically forms homodimers, a characteristic feature of the TGF-beta family, and interacts with specific receptors to mediate its effects (Ingman2002Defining). The gene's expression and the protein's activity are critical in various tissues, including the pancreas and heart, where they play roles in maintaining cellular identity and structural integrity (Azhar2011Transforming; Ibrahim2021βCell). Mutations in TGFB2 are associated with connective tissue disorders and vascular anomalies, highlighting its significance in human health and disease (Schepers2018A; Ritelli2014Further).

## Structure
The TGFB2 protein is a member of the TGF-beta superfamily and is initially synthesized as a precursor protein. This precursor undergoes cleavage to produce a mature peptide, which is essential for its biological activity (Weiss2012The). The mature TGFB2 protein features a cystine knot motif, a structural element that stabilizes the protein through disulfide bonds. This motif is common across the TGF-beta superfamily and is crucial for the protein's function (Weiss2012The).

In terms of quaternary structure, TGFB2 typically forms a homodimer, which is a common characteristic of TGF-beta family members. This dimerization is facilitated by a seventh cysteine residue that plays a key role in the formation of the dimeric structure (Weiss2012The).

Post-translational modifications of TGFB2 may include glycosylation and phosphorylation, which can influence its activity and interactions with other molecules (Weiss2012The). The protein's interaction with receptors is also modulated by additional transmembrane docking molecules, such as Betaglycan, which enhances the binding of TGFB2 to its receptors (Ingman2002Defining). These structural features are critical for the protein's role in signaling pathways and its involvement in various physiological processes.

## Function
Transforming growth factor beta 2 (TGFB2) is a crucial component of the TGF-β superfamily, which plays significant roles in various cellular processes, including cell growth, differentiation, and apoptosis. In healthy human cells, TGFB2 is involved in maintaining cellular identity and function, particularly in β-cells and heart development. In β-cells, TGFB2 is essential for preserving cellular identity and function by regulating the expression of key transcription factors and genes involved in insulin secretion. The downregulation of TGFB2, as mediated by miR-21, leads to β-cell dysfunction and dedifferentiation, highlighting its protective role in maintaining β-cell identity (Ibrahim2021βCell).

In heart development, TGFB2 is vital for proper valve remodeling and differentiation of mesenchymal cells. It regulates the extracellular matrix (ECM) organization and suppresses ectopic differentiation into cartilage, ensuring normal valve structure and function. TGFB2 deficiency results in impaired ECM organization, leading to valve thickening and developmental abnormalities, which can predispose individuals to valve diseases (Azhar2011Transforming). TGFB2's role in these processes underscores its importance in maintaining structural integrity and regulating signal transduction pathways in both pancreatic and cardiac tissues.

## Clinical Significance
Mutations in the TGFB2 gene are associated with several connective tissue disorders, most notably Loeys-Dietz syndrome type 4 (LDS4). This condition is characterized by vascular anomalies such as aortic aneurysms, dissections, and arterial tortuosity, along with skeletal and craniofacial features (Schepers2018A; Ritelli2014Further). Specific mutations, including missense, nonsense, and splice site mutations, can lead to altered TGF-β signaling, which is crucial in the pathology of these disorders (Schepers2018A). 

In addition to connective tissue disorders, TGFB2 mutations have been linked to corneal abnormalities, such as corneal thinning and cornea guttata, particularly in the context of LDS4 (Eghrari2020Corneal). Alterations in TGFB2 expression are also implicated in liver diseases, including primary sclerosing cholangitis and primary biliary cholangitis, where the gene is significantly upregulated, contributing to fibrogenesis and disease severity (Dropmann2020TGFβ2).

Furthermore, TGFB2 mutations have been identified in familial cases of non-syndromic aortic disease, suggesting a broader role in vascular pathologies beyond syndromic presentations (GagoDíaz2014Whole). These findings underscore the gene's critical role in maintaining vascular integrity and its involvement in various disease processes.

## Interactions
TGFB2 interacts with various proteins and plays a significant role in cellular processes through these interactions. It is capable of forming heterodimers with other proteins such as INHA and INHBB, which share similar cysteine mutations and disease phenotypes. These interactions are crucial in understanding the mechanisms of diseases like endometrial adenocarcinomas and Loeys-Dietz syndrome (Daly2022Computational). TGFB2 also shares phenotypes with TGFB3, suggesting a mechanism for heterodimer formation based on the b8 region (Daly2022Computational).

TGFB2 interacts with latent TGF-beta binding proteins (LTBP1, LTBP3, and LTBP4) through disulfide-dependent mechanisms, which are essential for its structural integrity and function (Daly2022Computational). The protein also interacts with SELE, which acts as a negative regulator of TGFB2 secretion (Daly2022Computational).

In the context of cancer, TGFB2 is involved in the regulation of endothelial cell growth and differentiation, particularly in prostate cancer, where it mediates the effects of cancer cells on bone marrow endothelial cells through TGFβ signaling (Barrett2005Prostate). These interactions highlight the multifaceted role of TGFB2 in cellular signaling and disease pathology.


## References


[1. (Schepers2018A) Dorien Schepers, Giada Tortora, Hiroko Morisaki, Gretchen MacCarrick, Mark Lindsay, David Liang, Sarju G. Mehta, Jennifer Hague, Judith Verhagen, Ingrid van de Laar, Marja Wessels, Yvonne Detisch, Mieke van Haelst, Annette Baas, Klaske Lichtenbelt, Kees Braun, Denise van der Linde, Jolien Roos-Hesselink, George McGillivray, Josephina Meester, Isabelle Maystadt, Paul Coucke, Elie El-Khoury, Sandhya Parkash, Birgitte Diness, Lotte Risom, Ingrid Scurr, Yvonne Hilhorst-Hofstee, Takayuki Morisaki, Julie Richer, Julie Désir, Marlies Kempers, Andrea L. Rideout, Gabrielle Horne, Chris Bennett, Elisa Rahikkala, Geert Vandeweyer, Maaike Alaerts, Aline Verstraeten, Hal Dietz, Lut Van Laer, and Bart Loeys. A mutation update on the lds-associated genestgfb2/3andsmad2/3. Human Mutation, 39(5):621–634, March 2018. URL: http://dx.doi.org/10.1002/humu.23407, doi:10.1002/humu.23407. This article has 126 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23407)

[2. (Dropmann2020TGFβ2) Anne Dropmann, Steven Dooley, Bedair Dewidar, Seddik Hammad, Tatjana Dediulia, Julia Werle, Vanessa Hartwig, Shahrouz Ghafoory, Stefan Woelfl, Hanna Korhonen, Michel Janicot, Katja Wosikowski, Timo Itzel, Andreas Teufel, Detlef Schuppan, Ana Stojanovic, Adelheid Cerwenka, Stefanie Nittka, Albrecht Piiper, Timo Gaiser, Naiara Beraza, Malgorzata Milkiewicz, Piotr Milkiewicz, John G Brain, David E J Jones, Thomas S Weiss, Ulrich M Zanger, Matthias Ebert, and Nadja M Meindl-Beinker. Tgf-β2 silencing to target biliary-derived liver diseases. Gut, 69(9):1677–1690, January 2020. URL: http://dx.doi.org/10.1136/gutjnl-2019-319091, doi:10.1136/gutjnl-2019-319091. This article has 32 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1136/gutjnl-2019-319091)

[3. (Weiss2012The) Alexander Weiss and Liliana Attisano. The tgfbeta superfamily signaling pathway. WIREs Developmental Biology, 2(1):47–63, October 2012. URL: http://dx.doi.org/10.1002/wdev.86, doi:10.1002/wdev.86. This article has 419 citations.](https://doi.org/10.1002/wdev.86)

[4. (Barrett2005Prostate) Jeffrey M. Barrett, Mark A. Rovedo, Aamair M. Tajuddin, Tamas Jilling, Jill A. Macoska, James MacDonald, Kathy A. Mangold, and Karen L. Kaul. Prostate cancer cells regulate growth and differentiation of bone marrow endothelial cells through tgfβ and its receptor, tgfβrii. The Prostate, 66(6):632–650, December 2005. URL: http://dx.doi.org/10.1002/pros.20370, doi:10.1002/pros.20370. This article has 15 citations.](https://doi.org/10.1002/pros.20370)

[5. (Azhar2011Transforming) Mohamad Azhar, Kristen Brown, Connie Gard, Hwudaurw Chen, Sudarsan Rajan, David A. Elliott, Mark V. Stevens, Todd D. Camenisch, Simon J. Conway, and Thomas Doetschman. Transforming growth factor beta2 is required for valve remodeling during heart development. Developmental Dynamics, 240(9):2127–2141, July 2011. URL: http://dx.doi.org/10.1002/dvdy.22702, doi:10.1002/dvdy.22702. This article has 59 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/dvdy.22702)

[6. (Ingman2002Defining) Wendy V. Ingman and Sarah A. Robertson. Defining the actions of transforming growth factor beta in reproduction. BioEssays, 24(10):904–914, September 2002. URL: http://dx.doi.org/10.1002/bies.10155, doi:10.1002/bies.10155. This article has 101 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/bies.10155)

[7. (Eghrari2020Corneal) Allen O. Eghrari, Marjohn M. Rasooly, Michael J. Fliotsos, Jessica Kinard, Obinna Odozor, Denise Cunningham, Rachel J. Bishop, Anthony L. Guerrerio, and Pamela A. Frischmeyer-Guerrerio. Corneal thinning and cornea guttata in patients with mutations in tgfb2. Canadian Journal of Ophthalmology, 55(4):336–341, August 2020. URL: http://dx.doi.org/10.1016/j.jcjo.2020.03.007, doi:10.1016/j.jcjo.2020.03.007. This article has 2 citations.](https://doi.org/10.1016/j.jcjo.2020.03.007)

[8. (Ibrahim2021βCell) Sara Ibrahim, Macey Johnson, Clarissa Hernandez Stephens, Jerry Xu, Rachel Moore, Andrea Mariani, Christopher Contreras, Farooq Syed, Raghavendra G. Mirmira, Ryan M. Anderson, and Emily K. Sims. Β-cell pre-mir-21 induces dysfunction and loss of cellular identity by targeting transforming growth factor beta 2 (tgfb2) and smad family member 2 (smad2) mrnas. Molecular Metabolism, 53:101289, November 2021. URL: http://dx.doi.org/10.1016/j.molmet.2021.101289, doi:10.1016/j.molmet.2021.101289. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmet.2021.101289)

[9. (Ritelli2014Further) Marco Ritelli, Nicola Chiarelli, Chiara Dordoni, Stefano Quinzani, Marina Venturini, Roberto Maroldi, Piergiacomo Calzavara-Pinton, and Marina Colombi. Further delineation of loeys-dietz syndrome type 4 in a family with mild vascular involvement and a tgfb2 splicing mutation. BMC Medical Genetics, August 2014. URL: http://dx.doi.org/10.1186/s12881-014-0091-8, doi:10.1186/s12881-014-0091-8. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12881-014-0091-8)

[10. (GagoDíaz2014Whole) Marina Gago-Díaz, Alejandro Blanco-Verea, Gisela Teixidó-Turà, Irene Valenzuela, Miguel Del Campo, Mar Borregan, Beatriz Sobrino, Jorge Amigo, David García-Dorado, Artur Evangelista, Ángel Carracedo, and María Brion. Whole exome sequencing for the identification of a new mutation in tgfb2 involved in a familial case of non-syndromic aortic disease. Clinica Chimica Acta, 437:88–92, November 2014. URL: http://dx.doi.org/10.1016/j.cca.2014.07.016, doi:10.1016/j.cca.2014.07.016. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cca.2014.07.016)

[11. (Daly2022Computational) Samantha M Daly, Ashley Peraza, and Stuart J Newfeld. Computational analysis of prodomain cysteines in human tgf-β proteins reveals frequent loss of disulfide-dependent regulation in tumors. G3 Genes|Genomes|Genetics, October 2022. URL: http://dx.doi.org/10.1093/g3journal/jkac271, doi:10.1093/g3journal/jkac271. This article has 2 citations.](https://doi.org/10.1093/g3journal/jkac271)